These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27057572)

  • 21. A case study of chewed Truvada
    Lalley-Chareczko L; Clark D; Zuppa AF; Moorthy G; Conyngham C; Mounzer K; Koenig H
    Antivir Ther; 2017; 22(7):639-641. PubMed ID: 28260694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethical considerations for new HIV prevention trials.
    Sugarman J; Celum CL; Donnell D; Mayer KH
    Lancet HIV; 2019 Aug; 6(8):e489-e491. PubMed ID: 31221591
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination Emtricitabine and Tenofovir Disoproxil Fumarate Prevents Vaginal Simian/Human Immunodeficiency Virus Infection in Macaques Harboring Chlamydia trachomatis and Trichomonas vaginalis.
    Radzio J; Henning T; Jenkins L; Ellis S; Farshy C; Phillips C; Holder A; Kuklenyik S; Dinh C; Hanson D; McNicholl J; Heneine W; Papp J; Kersh EN; García-Lerma JG
    J Infect Dis; 2016 May; 213(10):1541-5. PubMed ID: 26743846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Science, technology, power and sex: PrEP and HIV-positive gay men in Paris.
    Brisson J; Nguyen VK
    Cult Health Sex; 2017 Oct; 19(10):1066-1077. PubMed ID: 28276922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV Prevention Drug's Slow Uptake Undercuts Its Early Promise.
    Tuller D
    Health Aff (Millwood); 2018 Feb; 37(2):178-180. PubMed ID: 29401032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PrEP and the PrEPstars.
    Morgan J
    Lancet HIV; 2018 Nov; 5(11):e616. PubMed ID: 30104178
    [No Abstract]   [Full Text] [Related]  

  • 27. HOW DO I PAY FOR PrEP?
    Evans D
    Posit Aware; 2015; 27(5):18-9. PubMed ID: 26714339
    [No Abstract]   [Full Text] [Related]  

  • 28. MOVING FORWARD WITH PrEP. THE BASICS OF PrEP.
    Highleyman L
    Posit Aware; 2015; 27(5):2-3. PubMed ID: 26714333
    [No Abstract]   [Full Text] [Related]  

  • 29. [Not Available].
    Nau JY
    Rev Med Suisse; 2016 Aug; 12(526):1346-1347. PubMed ID: 28671781
    [No Abstract]   [Full Text] [Related]  

  • 30. Progress and pitfalls in measuring HIV preexposure prophylaxis coverage in the United States.
    Rosenberg ES; Marcus JL
    Ann Epidemiol; 2018 Dec; 28(12):830-832. PubMed ID: 30224292
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention.
    Mugwanya KK; Baeten JM
    Expert Opin Drug Saf; 2016; 15(2):265-73. PubMed ID: 26634852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of HIV Pre-Exposure Prophylaxis as Part of Routine Care in Toronto, Canada.
    Rajchgot J; Siemieniuk RA; Sivachandran N; Murphy P; Sharp A; Cicci A; Bogoch II
    J Acquir Immune Defic Syndr; 2016 Jul; 72(3):e80-1. PubMed ID: 27035886
    [No Abstract]   [Full Text] [Related]  

  • 33. Truvada (emtricitabine/tenofovir) pre-exposure prophylaxis roll-out among South African university students: Lots of positives, but let us keep an eye on possible surprises.
    Montjane K; Dlamini S; Dandara C
    S Afr Med J; 2018 Feb; 108(2):79-81. PubMed ID: 29429434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic-Based Methods of Adherence Assessment in HIV Prevention.
    Brooks KM; Anderson PL
    Clin Pharmacol Ther; 2018 Dec; 104(6):1056-1059. PubMed ID: 30178462
    [No Abstract]   [Full Text] [Related]  

  • 35. [EMA examines an application for change in authorization of truvada].
    Red
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259906
    [No Abstract]   [Full Text] [Related]  

  • 36. Reply to Sachdev et al.
    Karris MY; Beekmann SE; Mehta SR; Polgreen PM
    Clin Infect Dis; 2014 Jun; 58(12):1788. PubMed ID: 24729555
    [No Abstract]   [Full Text] [Related]  

  • 37. Intentions to prescribe preexposure prophylaxis are associated with self-efficacy and normative beliefs.
    Sachdev DD; Stojanovski K; Liu AY; Buchbinder SP; Macalino GE
    Clin Infect Dis; 2014 Jun; 58(12):1786-7. PubMed ID: 24729556
    [No Abstract]   [Full Text] [Related]  

  • 38. Murnane, Coley, and Baeten respond to "every good randomization deserves observation".
    Murnane PM; Coley RY; Baeten JM
    Am J Epidemiol; 2015 Nov; 182(10):861-2. PubMed ID: 26487341
    [No Abstract]   [Full Text] [Related]  

  • 39. Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.
    Tetteh RA; Yankey BA; Nartey ET; Lartey M; Leufkens HG; Dodoo AN
    Drug Saf; 2017 Apr; 40(4):273-283. PubMed ID: 28130774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Preexposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073.
    Zhang Y; Clarke W; Marzinke MA; Piwowar-Manning E; Beauchamp G; Breaud A; Hendrix CW; Cloherty GA; Emel L; Rose S; Hightow-Weidman L; Siegel M; Shoptaw S; Fields SD; Wheeler D; Eshleman SH
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.